GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Total Equity

Genix Pharmaceuticals (TSXV:GENX) Total Equity : C$-1.20 Mil (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Total Equity?

Genix Pharmaceuticals's total equity for the quarter that ended in Jan. 2024 was C$-1.20 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Genix Pharmaceuticals Total Equity Historical Data

The historical data trend for Genix Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Total Equity Chart

Genix Pharmaceuticals Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 4.86 4.01 3.20 -1.14

Genix Pharmaceuticals Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 2.74 2.57 -1.14 -1.20

Genix Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Genix Pharmaceuticals's Total Equity for the fiscal year that ended in Oct. 2023 is calculated as

Total Equity=Total Assets(Q: Oct. 2023 )-Total Liabilities(Q: Oct. 2023 )
=0.223-1.361
=-1.14

Genix Pharmaceuticals's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity=Total Assets(Q: Jan. 2024 )-Total Liabilities(Q: Jan. 2024 )
=0.247-1.443
=-1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals (TSXV:GENX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Total Equity
Comparable Companies
XCNQ:HERB XCNQ:BZAM XCNQ:MOJO XCNQ:CNTR XCNQ:STKT XCNQ:PHRX TSXV:LFST XCNQ:CPTR TSXV:ENTG XCNQ:XBRA ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
GENPF:USA
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Website
https://www.genixpharm.com
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.
Executives
Sina Pirooz Director

Genix Pharmaceuticals (TSXV:GENX) Headlines

No Headlines